<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">milmed</journal-id><journal-title-group><journal-title xml:lang="ru">Военная медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Military Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-5044</issn><publisher><publisher-name>Белорусский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51922/2074-5044.2024.1.49</article-id><article-id custom-type="elpub" pub-id-type="custom">milmed-164</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ НАУЧНЫЕ ПУБЛИКАЦИИ. Новые технологии в медицине</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL SCIENTIFIC PUBLICATIONS. New technologies in medicine</subject></subj-group></article-categories><title-group><article-title>Cтруктурно-функциональное ремоделирование миокарда у женщин и мужчин при симптомной и асимптомной гиперурикемии</article-title><trans-title-group xml:lang="en"><trans-title>STRUCTURAL-FUNCTIONAL REMODELING OF MYOCARDIAL IN WOMEN AND MEN WITH SYMPTOMIC AND ASYMPTOMIC HYPERURICEMIA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нехайчик</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nekhaichik</surname><given-names>Т. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bova</surname><given-names>A. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кудравец</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kudravec</surname><given-names>V. S.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Военно-медицинский институт в УО «Белорусский государственный медицинский университет»</institution><country>Belarus</country></aff><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>23</day><month>08</month><year>2026</year></pub-date><volume>0</volume><issue>1</issue><fpage>49</fpage><lpage>59</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Нехайчик Т.А., Бова А.А., Кудравец В.С., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Нехайчик Т.А., Бова А.А., Кудравец В.С.</copyright-holder><copyright-holder xml:lang="en">Nekhaichik Т.A., Bova A.A., Kudravec V.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://milmed.ejournal.by/jour/article/view/164">https://milmed.ejournal.by/jour/article/view/164</self-uri><abstract><p>Представлены результаты оценки влияния выраженности гиперурикемии, возраста и пола на формирование патологического структурно-функционального ремоделирования миокарда левого желудочка у пациентов с подагрой и асимптомной гиперурикемией. Установлена ключевая роль выраженности ГУ, а также ассоциация эксцентрической гипертрофии с мужским полом и дебютом подагры до 45 лет, концентрической гипертрофии – с умеренной асимптомной гиперурикемией и женским полом. Нарушения пуринового обмена развивались у женщин на 10 лет позже, на фоне высокой коморбидности. Обсуждаются перспективы ранней диагностики микрокристаллического воспаления для инициации урикостатической терапии при асимптомной гиперурикемии.</p></abstract><trans-abstract xml:lang="en"><p>The results of assessing the influence of the severity of hyperuricemia, age and gender on the forma- tion of pathological structural and functional remodeling of the left ventricular myocardium in patients with gout and asymptomatic hyperuricemia are presented. The key role of the severity of hyperuri- cemia has been established, as well as the association of eccentric hypertrophy with male gender and the onset of gout before 45 years of age, and concentric hypertrophy with moderate asympto- matic hyperuricemia and female gender. Purine metabolism disorders developed in women 10 years later, against the background of high comorbidity. The prospects for early diagnosis of microcrystalline inflammation to initiate uricostatic therapy for asymptomatic hyperuricemia are discussed.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>подагра</kwd><kwd>асимптомная гиперурикемия</kwd><kwd>патологическое ремоделирование миокарда</kwd><kwd>микрокристаллическое воспаление</kwd></kwd-group><kwd-group xml:lang="en"><kwd>gout</kwd><kwd>asymptomatic hyperuricemia</kwd><kwd>pathological myocardial remodeling</kwd><kwd>microcrys- talline inflammation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gusev E, Sarapultsev A. Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes. Int J Mol Sci. 2023 Apr 26;24(9):7910. doi: 10.3390/ijms24097910. PMID: 37175617.</mixed-citation><mixed-citation xml:lang="en">Gusev E, Sarapultsev A. Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes. Int J Mol Sci. 2023 Apr 26;24(9):7910. doi: 10.3390/ijms24097910. PMID: 37175617.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Рамеев В.В., Елисеев М.С., Моисеев С.В. Концепция аутовоспаления в генезе подагры и гиперурикемии. Клин фармакол тер 2019;28(2):28- 33. DOI 10.32756/0869-5490-2019-2-28-33.</mixed-citation><mixed-citation xml:lang="en">Rameev V.V., Eliseev M.S., Moiseev S.V. Konczepcziya autovospaleniya v geneze podagry` i giperurikemii. Klin farmakol ter 2019;28(2):28-33. (In Russ.). DOI 10.32756/0869-5490-2019-2-28-33.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lin KC, Lin HY, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 2000; 27 (6): 1501–5</mixed-citation><mixed-citation xml:lang="en">Lin KC, Lin HY, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 2000; 27 (6): 1501–5</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Yu W, Cheng JD. Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective. Front Pharmacol. 2020 Nov 16;11:582680. doi: 10.3389/fphar.2020.582680. eCollection 2020</mixed-citation><mixed-citation xml:lang="en">Yu W, Cheng JD. Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective. Front Pharmacol. 2020 Nov 16;11:582680. doi: 10.3389/fphar.2020.582680. eCollection 2020</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kuo CF, Luo SF. Gout: Risk of premature death in gout unchanged for years. Nat Rev Rheumatol. 2017 Apr;13(4):200-201. doi: 10.1038/nrrheum.2017.27. Epub 2017 Mar 2.</mixed-citation><mixed-citation xml:lang="en">Kuo CF, Luo SF. Gout: Risk of premature death in gout unchanged for years. Nat Rev Rheumatol. 2017 Apr;13(4):200-201. doi: 10.1038/nrrheum.2017.27. Epub 2017 Mar 2.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Головач ИЮ, Егудина ЕД, Ханюков АА. Подагра, кардиоваскулярные риски и сердечно-сосудистые заболевания: кристаллическая неразбериха. Артерiальна гiпертензiя. 2019; 2(64):45–51.</mixed-citation><mixed-citation xml:lang="en">Golovach IYu, Egudina ED, Khanyukov AA. Podagra, kardiovaskulyarny`e riski i serdechno-sosudisty`e zabolevaniya: kristallicheskaya nerazberikha. Arterial`na gipertenziya. 2019;2(64):45–51. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Желябина ОВ, Елисеев МС. Уратснижающая терапия при сердечной недостаточности. Современная ревматология. 2019;13(3):109–115.</mixed-citation><mixed-citation xml:lang="en">Zhelyabina OV, Eliseev MS. Uratsnizhayushhaya terapiya pri serdechnoj nedostatochnosti. Sovremennaya revmatologiya. 2019;13(3):109–115. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bardin T., Richette P. Definition of hyperuricemia and gouty conditions // Curr. Opin. Rheumatol. 2014. Vol. 26. № 2. P. 186–191.</mixed-citation><mixed-citation xml:lang="en">Bardin T., Richette P. Definition of hyperuricemia and gouty conditions // Curr. Opin. Rheumatol. 2014. Vol. 26. № 2. P. 186–191.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Галушко ЕА, Насонов ЕЛ. Распространенность ревматических заболеваний в России. Альманах клинической медицины. 2018;46(1):32–9. doi: 10.18786/2072-0505-2018-46-1-32-39.</mixed-citation><mixed-citation xml:lang="en">Galushko EA, Nasonov EL. Rasprostranennost` revmaticheskikh zabolevanij v Rossii. Al`manakh klinicheskoj medicziny`. 2018;46(1):32–9. (In Russ.). doi: 10.18786/2072-0505-2018-46-1-32-39.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu Y., Pandya B.J., Choi H.K. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008 // Arthritis Rheum. 2011. Vol. 63. № 10. P. 3136–3141.</mixed-citation><mixed-citation xml:lang="en">Zhu Y., Pandya B.J., Choi H.K. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008 // Arthritis Rheum. 2011. Vol. 63. № 10. P. 3136–3141.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Шальнова С.А., Деев А.Д., Артамонова Г.В. и др. Гиперурикемия и ее корреляты в российской популяции (результаты эпидемиологического исследования ЭССЕ-РФ). Рациональная фармакотерапия в кардиологии. 2014; 10 (2): 153–9.</mixed-citation><mixed-citation xml:lang="en">Shal`nova S.A., Deev A.D., Artamonova G.V. i dr. Giperurikemiya i ee korrelyaty` v rossijskoj populyaczii (rezul`taty` e`pidemiologicheskogo issledovaniya E`SSE-RF). Raczional`naya farmakoterapiya v kardiologii. 2014; 10 (2): 153–9. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Liu B, Wang T, Zhao HN et al. The prevalence of hyperuricemia in China: a meta-analysis. BMC Public Health 2011; 11: 832.</mixed-citation><mixed-citation xml:lang="en">Liu B, Wang T, Zhao HN et al. The prevalence of hyperuricemia in China: a meta-analysis. BMC Public Health 2011; 11: 832.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Жернакова Ю.В., Кисляк О.А. и др. Консенсус по ведению пациентов с гиперурикемией и высоким сердечно-сосудистым риском. Системные гипертензии. 2019; 16 (4): 8–21. DOI: 10.26442/2075082X.2019.4.190686</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., Zhernakova Yu.V., Kislyak O.A. i dr. Konsensus po vedeniyu paczientov s giperurikemiej i vy`sokim serdechno-sosudisty`m riskom. Sistemny`e gipertenzii. 2019; 16 (4): 8–21. (In Russ.)]. DOI: 10.26442/2075082X.2019.4.190686</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Te Kampe R, Janssen M, van Durme C, et al. Sex differences in the clinical profile among patients with gout: cross-sectional analyses of an observational study. J Rheumatol 2021; 48: 286–292.</mixed-citation><mixed-citation xml:lang="en">Te Kampe R, Janssen M, van Durme C, et al. Sex differences in the clinical profile among patients with gout: cross-sectional analyses of an observational study. J Rheumatol 2021; 48: 286–292.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sivera F, Andres M, Dalbeth N. A glance into the future of gout. Ther Adv Musculoskelet Dis. 2022;14:1759720X221114098. Published 2022 Jul 28. doi:10.1177/1759720X221114098</mixed-citation><mixed-citation xml:lang="en">Sivera F, Andres M, Dalbeth N. A glance into the future of gout. Ther Adv Musculoskelet Dis. 2022;14:1759720X221114098. Published 2022 Jul 28. doi:10.1177/1759720X221114098</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lijun Li, Maoxiang Zhao, Chi Wang et al. Early onset of huperuricemia is associated with increased cardiovascular disease and mortality risk // Clinical Research of Cardiology. 2021: 1: 15-24.</mixed-citation><mixed-citation xml:lang="en">Lijun Li, Maoxiang Zhao, Chi Wang et al. Early onset of huperuricemia is associated with increased cardiovascular disease and mortality risk // Clinical Research of Cardiology. 2021: 1: 15–24.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Son CN, Stewart S, Su I, et al. Global patterns of treat-to-serum urate target care for gout: systematic review and meta-analysis. Semin Arthritis Rheum 2021; 51: 677–684.</mixed-citation><mixed-citation xml:lang="en">Son CN, Stewart S, Su I, et al. Global patterns of treat-to-serum urate target care for gout: systematic review and meta-analysis. Semin Arthritis Rheum 2021; 51: 677–684.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Желябина О. В., Чикина М. Н., Елисеев М. С. Применение аллопуринола при подагре // Доктор. Ру. 2017. № 10 (139). С. 57–62.</mixed-citation><mixed-citation xml:lang="en">Zhelyabina O. V., Chikina M. N., Eliseev M. S. Primenenie allopurinola pri podagre // Doktor.Ru. 2017. N 10 (139). S. 57–62. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Взаимосвязь гиперурикемии со структурно-функциональными показателями сердца у пациентов с артериальной гипертензией и фибрилляцией предсердий / Т. Л. Борисенко, В. А. Снежицкий, М. Н. Курбат, Г. А. Мадекина, Е. Н. Черная, Ж. Г. Епифанова // Журнал Гродненского государственного медицинского университета. 2022. Т. 20, № 2. С. 187–196. https://doi.org/10.25298/2221-8785-2022-20-2-187-196.</mixed-citation><mixed-citation xml:lang="en">Vzaimosvyaz` giperurikemii so strukturnofunkczional`ny`mi pokazatelyami serdcza u paczientov s arterial`noj gipertenziej i fibrillyacziej predserdij / T. L. Borisenko, V. A. Snezhiczkij, M. N. Kurbat, G. A. Madekina, E. N. Chernaya, Zh. G. Epifanova // Zhurnal Grodnenskogo gosudarstvennogo mediczinskogo universiteta. 2022. T. 20, N 2. S. 187– 196. (In Russ.) https://doi.org/10.25298/2221-8785-2022-20-2-187-196.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Prognositc Value of Urc acid Levels in Elderly Chronic Heart Failure Patients / Y. Mitsuke [et al.] // J. Cardiac Fail. – 2013. – Vol. 19, № 10 (suppl). – P. 138. – doi: 10.1016/j.cardfail.2013.08.166.</mixed-citation><mixed-citation xml:lang="en">Prognositc Value of Urc acid Levels in Elderly Chronic Heart Failure Patients / Y. Mitsuke [et al.] // J. Cardiac Fail. – 2013. – Vol. 19, N 10 (suppl). – P. 138. – doi: 10.1016/j.cardfail.2013.08.166.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
